openPR Logo
Press release

Social Problems due to Drug Abuse Driving Substance Abuse Treatment Market

11-11-2016 01:34 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Social Problems due to Drug Abuse Driving Substance Abuse

Substance abuse refers to the use of psychoactive substances, which include alcohol and illicit drugs, to the extent that it is harmful or hazardous. Psychoactive substance abuse can lead to dependence syndrome – a cluster of behavioral, physiological, and cognitive symptoms stemming from the body’s reaction to a lack of the respective substance. This develops as a result of continual use of the substance and typically involve a strong urge to take the drug, difficulty to control the use of the drug, persistent use of the drug despite harmful effects, and higher priority to drug use over other activities and obligations.

Interpret the Prospective Trends for the Treatment of Substance Abuse at:
https://goo.gl/y7NStc

The reasons for substance abuse are many – chaotic domestic environment, poor social skills, and genetic risks are some of the reasons that lead to substance abuse. Aggressive behavior, irritability, and forgetfulness are some of the symptoms indicative of substance abuse. Early recognition of symptoms related with substance abuse leads to a higher chance of successful treatment. The global substance abuse treatment market is segmented into alcohol, drug abuse therapeutics, and nicotine dependence therapeutics.

Substance Abuse Treatment Works Best in Combination with other Support Therapies

A large number of studies carried out for substance abuse treatment support the notion that a combination of behavioral therapy/counselling and medications is the best-suited mode for treating patients. This is needed, as long-term use of drugs changes brain function so as to make resisting the urge to use the drugs a harder choice. Thus, prevention of relapse is one of the most important aspects of substance abuse treatment.

The substance abuse treatment market is primarily driven by factors such as increased awareness and financial assistance for mental well-being in long-term substance abuse treatment. In addition, the increasing prevalence of substance abuse illnesses due to physical, social, and economic reasons is contributing to the growth of this market. This, in turn, is boosting the number of mental and substance abuse centers.

Other factors such as the high annual treatment cost and regulatory mandates for substance abuse treatment affect the growth of this market negatively and positively, respectively. The latter could negate the influence of the former in the long run, making substance abuse treatment affordable for all and boosting the global market for the same. Factors such as the lack of willingness to seek treatment slow the growth of this market.

Complementary Medication Necessary to Treat Drug Abuse Effectively

Zyban and Chantix (vareniciline) are some of the medications used against nicotine addiction. In addition, drugs such as Campral (acamprosate calcium), Disulfrum, and Vivitrol (naltrexone) are recommended for patients suffering from alcohol dependency. Some of the commonly used drugs against which drug abuse treatment is applied are cocaine and opioids.

The prescription drugs for a specific substance abuse condition are complemented with certain medications that help resist the urge and manage secondary medical conditions resulting from substance abuse. For example, methadone and nicotine patches help control drug cravings and withdrawal symptoms.

Read the Latest Market Projections of Substance Abuse Treatment at: http://www.transparencymarketresearch.com/substance-abuse-treatment-market.html

As a part of substance abuse treatment, patients are advised to seek immediate medical help in the event of an unexpected deviation in mental and physical health. Along with this, behavioral therapy is an important component of substance abuse treatment. This helps patients resist the urge for use of drugs and avoid relapse.

Some of the major companies operating in the global substance abuse treatment market are Teva Pharmaceutical Industries Ltd., Alkermes Plc, Pfizer Inc., GlaxoSmithkline Plc, and Reckitt Benckiser Pharmaceuticals Inc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Social Problems due to Drug Abuse Driving Substance Abuse Treatment Market here

News-ID: 381773 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Abuse

Drug for Abuse Testing Devices Market
Drugs for abuse testing device offer testing methods to detect drugs present in the human body by analyzing saliva, blood, urine, and sweat. The drug for abuse testing devices market comprises kits and devices, which help in measuring drug intake. Tests can be conducted at home as well as in laboratories. The test uses immunoassay to screen different samples and includes the confirmation of screening results by definitive analytical techniques
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any
Substance Abuse Treatment Market: Alarming Rise in Cases of Substance Abuse Driv …
U.S. Substance Abuse Treatment Market: Snapshot In the U.S. Substance abuse has become a major cause of concern. People in this country are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes and cardiovascular disorders, have increased substantially among consumers, creating a
Handling FMLA Abuse
Edupliance announces webinar titled, “Handling FMLA Abuse” that aims to help attendees to understand how do they identify the FMLA abuse and what can they do about it. The event going to be held LIVE on, Nov 21, 2017 from 1 PM - 02:30 PM ET/ 10 AM - 11:30 AM PT. Since the Family and Medical Leave Act (“FMLA”) was signed into law, employers have been faced with the
Substance Abuse Treatment Market | Evolving Market Trends
U.S. Substance Abuse Treatment Market: Snapshot  In the U.S. Substance abuse has become a major cause of concern. People in this country are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes and cardiovascular disorders, have increased substantially among consumers, creating a high
03-16-2017 | Health & Medicine
TMR
Drugs of Abuse Testing Market: High Prevalence of Drug Abuse Augurs Well for Ove …
Drugs of abuse testing offer a variety of testing methods that can be conducted at home as well as in laboratories to detect drugs present in the human body. These drugs are tested through saliva, blood, and sweat. The testing of drugs is done for drugs that are banned by governments. Analysts anticipate that the global market will witness a considerable growth rate in the coming years due to